Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Stem Cell Umbilical Cord Blood Market?

The market for stem cell umbilical cord blood has seen significant expansion recently. The market size is projected to increase from $6.77 billion in 2024 to $7.98 billion in 2025, evidencing a compound annual growth rate (CAGR) of 17.8%. This upward trajectory during the historical period can be linked to augmented research and development, heightened demand for private banking services, an escalating number of clinical trials, a rising incidence of cancer cases, and an increase in the number of fertility clinics.

The market size for stem cell umbilical cord blood is predicted to experience swift expansion in the upcoming years, escalating to $15.21 billion by 2029 with a compound annual growth rate (CAGR) of 17.5%. Factors that contribute to this growth during the projected period are the increased prevalence of chronic diseases, rise in childbirth rates, growing demand for stem cell therapies, enhanced government policies and initiatives, along with a heightened focus on regenerative medicine. Significant trends to observe during this forecast period involve advancements in therapeutic applications, improvement in healthcare infrastructure, progress in cryopreservation techniques, and incorporation with gene therapy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24715&type=smp

Which Factor Is Shaping The Future Of The Stem Cell Umbilical Cord Blood Market?

The surge in birth rates are projected to stimulate the expansion of the stem cell umbilical cord blood market in the future. The number of children born, measuring as live births per 1k individuals in a specific population over a predetermined period – ordinarily a year, defines childbirth rates. The rise in these rates is attributed to the increased accessibility and affordability of fertility therapies, allowing more families to conceive. Critical for newborns, umbilical cord blood stem cells carry hematopoietic stem cells, capable of treating diverse blood, immune, and genetic diseases. These cells are an excellent genetic match for the infant and may potentially assist siblings or other family members. For example, as per the U.S. Centers for Disease Control and Prevention, a federal agency based in the U.S., there was a 1% rise in U.S. births, with the number accelerating from 3,596,017 in 2023 to 3,622,673 in 2024. This uptick in childbirth rates, therefore, serves as a key driver for the stem cell umbilical cord blood market’s growth.

What Is The Segment-Wise Breakdown Of The Stem Cell Umbilical Cord Blood Market?

The stem cell umbilical cord blood market covered in this report is segmented –

1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells

2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation

3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks

4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users

Subsegments:

1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells

2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells

Which Trends Are Redefining The Future Landscape Of The Stem Cell Umbilical Cord Blood Industry?

Companies which are dominant in the stem cell umbilical cord blood industry are prioritizing the development of groundbreaking therapies and securing approvals. This includes cord blood cell treatment designed to address rare genetic conditions, bolster immune system recovery, and enable regenerative medicine applications. Cord blood cell treatment employs stem cells extracted from umbilical cord blood to rectify a variation of ailments through the restoration or repair of damaged blood, immune, and various tissue systems. For example, StemCyte, a biotechnology firm based in the U.S, achieved the advanced regenerative medicine therapy designation from the U.S. Food and Drug Administration (FDA) in October 2024 for their hematopoietic progenitor cell cord blood therapy (HPC Cord Blood) designed to treat Long COVID-19 syndrome. This cord blood cell therapy uses stem cells from umbilical cord blood to hasten healing and minimize inflammation. It’s demonstrated potential in managing immune and degenerative conditions, and provides a non-invasive, ethically sourced approach to advanced regenerative treatments.

Which Companies Hold The Largest Market Share In The Stem Cell Umbilical Cord Blood Sector?

Major companies operating in the stem cell umbilical cord blood market are Takeda Pharmaceutical Company Limited, Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co. Ltd., Smart Cells International Ltd., StemCyte Inc., Celularity Inc., Next Biosciences Pty Ltd, Esperite N.V., Cryo-Cell International Inc., FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt. Ltd., Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc., Cord Blood Registry.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/stem-cell-umbilical-cord-blood-global-market-report

How Does Regional Performance Compare Across The Stem Cell Umbilical Cord Blood Industry?

North America was the largest region in the stem cell umbilical cord blood market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24715&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model